Stay updated on Nivolumab Combo Therapy in Virus Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page.

Latest updates to the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page
- Check6 days agoChange DetectedA new publication citation for a 2021 J Immunother Cancer article on CheckMate 358 has been added, and the Erratum entry for that article has been deleted.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new Revision: v3.5.3 is displayed, replacing the previous Revision: v3.5.2, indicating a minor version update in the page metadata.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new publication entry for Ferris et al. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial, with an erratum, and updated the record revision to v3.5.2. Removed the older Ferris et al. J Immunother Cancer, 2021 citation and revision 3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision: v3.4.2 is now listed, and the funding-status notice along with Revision: v3.4.1 have been removed. These changes affect site maintenance notes, not the study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Combo Therapy in Virus Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page.